首页 >
法规速递
-
Document: Meeting summary - PCWP/HCPWP and all eligible organisations meeting 18 November 2025-2025/12/9
2025-12-10查看详情 > -
Document: Consolidated 3-year rolling work plan for the Non-clinical domain 2026-2028-2026/1/21
2026-01-22查看详情 > -
Document: Electronic reporting to EudraVigilance - List of reference documents-2026/2/24
2026-02-27查看详情 > -
Page: Type-II variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Document: List of industry subject matter experts and list of planned calls for industry subject matter experts-2026/5/7
2026-05-08查看详情 > -
Page: CVMP recommendations on limited market classification and eligibility for authorisation under Article 23-2026/6/22
2026-06-23查看详情 > -
Scientific guideline: ICH M11 template - Step 2b-2022/10/26
2022-11-15查看详情 > -
Regulatory and procedural guideline: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure-2023/4/25
2023-04-26查看详情 > -
国家药监局药审中心关于印发《药品审评中心药物临床试验期间安全信息评估与风险管理工作程序（试行）》的通知-2023/11/3
2023-11-07查看详情 > -
Document: Minutes - HMA-EMA joint Big Data Steering Group teleconference - 11 December 2024-2025/1/14
2025-01-15查看详情 >
